These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Diclofenac-Na--an alternative treatment possibility in therapy-resistant calcium oxalate urolithiasis?]. Brundig P; Pirlich W; Börner RH; Wittig E Urologe A; 1986 Jul; 25(4):204-8. PubMed ID: 3765223 [TBL] [Abstract][Full Text] [Related]
43. Hyperuricosuria and calcium nephrolithiasis. Coe FL; Parks JH Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958 [No Abstract] [Full Text] [Related]
44. The measurement of intestinal calcium absorption by external radioisotope counting in patients with recurrent nephrolithiasis. Wills MR; Bartter FC Clin Sci; 1969 Dec; 37(3):875. PubMed ID: 5363586 [No Abstract] [Full Text] [Related]
45. [Treatment of calcium oxalate calculi using Reducto-Special]. Swoboda G Wien Med Wochenschr; 1977 Jun; 127(13):431-2. PubMed ID: 899035 [No Abstract] [Full Text] [Related]
46. [Significance of mucopolysaccharide structural changes in the pathogenesis and diagnosis of nephrolithiasis]. Borisova-Khromenko VM; Berezin IuV; Maletin AG; Neĭmark AI Urol Nefrol (Mosk); 1981; (1):18-20. PubMed ID: 6451975 [No Abstract] [Full Text] [Related]
47. Intestinal absorption of 47Ca in patients with calcium renal stones. Odavić M; Ivković L; Mićić R; Antić M; Savić B Acta Med Iugosl; 1974; 28(2):123-33. PubMed ID: 4839750 [No Abstract] [Full Text] [Related]
48. [On the question of endocrine side effects in patients on medication for renal calcium stone disease (author's transl)]. Ziegler R; Uhl K; Minne H; Russmann D; Döring B Urologe A; 1980 Jul; 19(4):226-30. PubMed ID: 7414768 [TBL] [Abstract][Full Text] [Related]
49. [Inhibitors of crystallization and calcium nephrolithiasis]. Baumann JM Ther Umsch; 1980 May; 37(5):363-72. PubMed ID: 6248999 [No Abstract] [Full Text] [Related]
51. Evaluation of calcium and phosphate metabolism in patients affected by essential hypertension and calcium nephrolithiasis. Malberti F; Surian M; Colussi G; Cosci P; Corradi B; Benazzi E; Minetti L Am J Nephrol; 1986; 6 Suppl 1():131-3. PubMed ID: 3826147 [No Abstract] [Full Text] [Related]
52. Re: Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. Assimos DG J Urol; 2015 Mar; 193(3):897-8. PubMed ID: 25765394 [No Abstract] [Full Text] [Related]
53. [Metaphylaxis on the basis of outpatient metabolic tests in nephrolithiasis]. Hiblbauer J; Base J; Zita K Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(3):379-84. PubMed ID: 3206213 [No Abstract] [Full Text] [Related]
54. [Effect of hydrochlorothiazide on calcium-magnesium parameters in patients with recurrent nephrolithiasis]. Musialik D; Głuszek J; Raszeja-Wanic B Pol Tyg Lek; 1978 Jul; 33(30):1173-5. PubMed ID: 693386 [No Abstract] [Full Text] [Related]
55. [What has been achieved in the therapy of calcium nephrolithiasis?]. Tschöpe W; Ritz E Internist (Berl); 1979 Dec; 20(12):599-606. PubMed ID: 398355 [No Abstract] [Full Text] [Related]